Did everybody hear the news about histogen???
Histogen lives!!! see i told you desmond.
Collapse
X
-
Tags: None
-
Comment
-
-
If they had anything that worked, they'd have been bought out. That's what so many of you don't understand - if these poorly-capitalized biotech start-ups ever hit gold, they'd be bought by a major pharma. That's when we'll know something that works has been developed, when some tiny bio-tech developing hair protocols are purchased by one of the big players.Comment
-
Source OP?
Below is a link to a Histogen Investor Presentation. If you see the projected revenues for HSC (slide 22), you will see Japan starts in 2018 and US in 2020.
On the last slide it states what the Series D funding will be used for:- US Phase I for HSC (female)
- Pivotal HSC trial in Asia
- IPO in the TSE or NASDAQ
- Expansion of manufacturing capacity.
Note the pivotal trial in Asia. Therefore another trial is need before release in Asia (Phase II?). Unfortunately, in their Long Promo video (published July), it seems they have not yet completed the Series D funding.
Unless circumstances have changed, I don't see the 2016 launch of HSC in Japan.
Hopefully by 2018 we will have HSC and RepliCel (Shiseido) after all these years waiting. That is at least the current projections by both companies.
Comment
-
It won't be out in 2016 in Japan that's just what a wishful poster said in one of the threads on this forum.
I wonder what they have to say on congress though, it seems even heavy lawsuits arnt enough to stop them raising funds after court... slightly optimistic.Comment
Comment